The startup provides digital, personalised therapy for use both in hospitals and at home and is focused on upper limb rehabilitation. The UK startup also has a significant presence in the US, where it partnered with medical equipment distributor Medline last month.“We are hopeful that GripAble can reproduce its strong initial success in the UK in the significantly larger US market,” said Martin Glen, investment director at Parkwalk Advisors.“This would enable many more patients to access the sustained level of rehabilitation therapy that they require for a positive outcome post-injury.”The company was initially funded by the Imperial College Innovation Fund, managed by Parkwalk Advisors. London-based GripAble provides rehabilitation programmes for patients with both neurological and musculoskeletal conditions. Founded in 2017, GripAble currently says more than 8,000 people have used the platform to carry out a combined 100,000 activity sessions.